INFORMED.
LIVE

ROSSARI BIOTECH LIMITED

BSE: ROSSARI543213ISIN INE02A801020
  • Commodities
  • Specialty Chemicals
  • BSE 1000

Share price

₹437.50-3.95 (-0.89%)
as of 18 Sep 2026
ROSSARI BIOTECH LIMITED share price, 18 Sep 2025 to 18 Sep 2026: ₹647.50 to ₹437.50 (-32.4%). Low ₹398.50, high ₹670.80. Volume shown below the price.
52W high
₹690.90
52W low
₹372.90
Off 52W high
-36.68%
1M return
-11.88%
3M return
-21.91%
6M return
+6.71%
1Y return
-32.43%
20D avg volume
4,377
50 DMA
₹494.25
200 DMA
₹511.95

Key ratios Consolidated

Market cap
₹2,423 Cr
Current price
₹437.50
52W high / low
₹690.90 / ₹372.90
Face value
₹2.00
P/E
16.08
P/B
EPS (TTM)
₹27.21
Book value / share
ROE
ROCE
15.30%
Operating margin
Net margin
Debt / equity
0.31
Net debt
₹332.68 Cr
Interest cover
8.03
Dividend yield
0.11%
Dividend / share (TTM)
₹0.50
Payout
1.84%
Cash conversion cycle
97.2 days

About

In plain English

Rossari Biotech is a specialty chemicals company that makes and sells industrial chemicals used in various manufacturing processes. Without specific product details from the provided materials, we can't name exact applications or customers, but it likely supplies to industries like textiles, home care, or industrial cleaning. The company operates through several business segments, but the exact nature of these segments is not disclosed here. As a publicly traded firm, it reports quarterly financial results and holds annual general meetings, indicating it is an established entity. However, the available information is too thin to describe its products or customers concretely.

AI-generated summary, written from the company's own filings and disclosures. Every figure elsewhere on this page comes from exchange data, not from a model. See our editorial standards. Generated 11 Jul 2026.

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
697.20684.86581.68586.11543.72579.56
3.1919.070.511.601.201.79
653.17640.20540.09538.51499.34533.79
514.68444.47417.60407.21334.40369.77
14.6624.1010.9729.3928.9633.88
44.0439.2340.2637.8037.4735.49
10.989.067.676.095.735.50
25.6123.5319.6118.2317.7518.22
81.7172.6671.7575.5367.0572.93
47.2263.7342.1049.2045.5847.56
0.000.000.000.000.000.00
47.2263.7342.1049.2045.5847.56
12.5818.289.7312.8012.5013.26
35.0945.9732.7736.8833.6034.44
6.348.305.926.666.076.22
Key metrics
83.8196.3269.3873.5269.0671.28
12.00%14.10%11.90%12.50%12.70%12.30%
5.00%6.70%5.60%6.30%6.20%5.90%
4.90%3.80%3.90%
28.20%18.20%
4.40%33.50%
MetricTTMFY26FY25FY24
Income statement
2,5502,3962,080
24.3722.384.01
2,3722,2181,900
1,7841,6041,300
79.1293.42164.77
161.33154.75132.33
33.8028.5417.81
86.9879.1267.07
301.65286.99249.59
202.25200.61184.21
0.000.000.00
202.25200.61184.21
53.3953.3048.81
150.71149.21136.38
27.2226.9524.66
Key metrics
323.03308.27269.09
12.67%12.90%12.90%
5.91%6.20%6.60%
15.30%14.90%
15.20%
9.40%
-199.60-21.07
0.441.01
0.310.16
332.68143.77
97.295.4
Balance sheet
2,2891,896
1,2361,042
75.3144.20
557.41474.50
404.55355.08
139.5693.39
560.54353.53
323.45286.33
789.56536.57
407.99187.97
313.6687.94
94.33100.03
1,3331,185
Cash flow
65.07137.44
-219.48-183.69
186.3264.90
264.67158.51
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
482.27516.14450.66419.51365.76426.65
2.1922.731.141.401.742.40
438.04465.32411.70378.94332.06385.19
294.39328.89274.93250.87211.74258.67
75.5558.0458.5571.7950.0861.82
20.3917.7518.7317.3115.6715.76
3.843.813.952.493.093.08
8.348.977.477.347.157.66
49.2743.6045.5343.3434.9842.88
46.4273.5540.1041.9735.4443.86
0.000.000.000.000.000.00
46.4273.5540.1041.9735.4443.86
12.1518.829.4710.729.2111.49
34.2754.7330.6331.2526.2332.36
6.199.885.535.644.745.85
Key metrics
58.6086.3351.5251.8045.6854.60
12.20%16.70%11.40%12.30%12.50%12.80%
7.10%10.60%6.80%7.40%7.20%7.60%
6.20%3.90%4.30%
31.90%21.00%
30.70%69.10%
MetricTTMFY26FY25FY24
Income statement
1,8691,7521,432
27.4627.015.74
1,6941,5881,283
1,1491,066811.12
263.93238.46253.00
74.1869.4660.01
14.0913.359.58
32.1230.9327.69
181.74167.45138.31
202.04191.06154.70
0.000.000.00
202.04191.06154.70
51.1648.2239.96
150.88142.84114.74
27.2425.7920.75
Key metrics
248.25235.34191.97
13.29%13.40%13.40%
8.07%8.20%8.00%
16.50%15.00%
22.40%
24.50%
-60.0139.23
0.410.80
0.100.03
77.8617.23
69.068.2
Balance sheet
1,7641,451
903.00696.95
48.6512.91
518.43374.60
179.73178.83
39.7939.07
211.17170.99
366.82285.93
521.19354.32
126.5130.14
121.3930.14
5.120.00
1,2181,077
Cash flow
58.7392.20
-101.40-69.92
79.13-32.27
118.7452.97

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
68.15%
HolderTypeHoldingPreviousChange
Edward MenezesPromoter29.10%
Sunil Srinivasan ChariPromoter13.16%
Chari Family Trust in the name of Sunil Srinivasan Chari and Jyotishna Sunil ChariPromoter Group9.23%
Uti-Flexi Cap FundPublic6.36%
Rossari Biotech India Private LimitedPromoter Group5.45%
Jyotishna Sunil ChariPromoter Group4.51%
Yash Sunil ChariPromoter Group4.45%
Life Insurance Corporation Of IndiaPublic4.01%
Canara Robeco Mutual Fund A/C Canara Robeco Small Cap FundPublic1.90%
Anita MenezesPromoter Group1.81%
Motilal Oswal Small Cap FundPublic1.42%
Mikhail MenezesPromoter Group0.24%
Menezes Family Trust in the name of Edward Walter Menezes and Anita MenezesPromoter Group0.20%
Priyata ChopraPromoter Group0.00%
Henry MenezesPromoter Group0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 0.500010 Jul 202610 Jul 2026
Final Dividend - Rs. - 0.500020 Jun 202520 Jun 2025
E.G.M.4 Nov 2024
Final Dividend - Rs. - 0.500016 Aug 2024

Board meetings

  • Board Meeting - Financial Results